Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 207 Queens Quay W, Toronto,ontario M5j1a7,canada
- Phone
- +1 (416) 304-9201
- in****@****arx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cyclicarx.com
- Keywords
- Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, bioinformatics.
- HQ
- Toronto, Ontario
Cyclica (Acquired By Recursion, Nasdaq: Rxrx) Questions
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s helpline number is +1 (416) 304-9201
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s website is cyclicarx.com
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s LinkedIn profile is https://ca.linkedin.com/company/cyclica
Cyclica (Acquired By Recursion, Nasdaq: Rxrx) has
3 employees.
View email and phone details for 3
employees at Cyclica (Acquired By Recursion, Nasdaq: Rxrx).
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s industry is
Biotechnology Research
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s top competitors are
Benevolentai,
Bluerock Therapeutics,
Exscientia,
Recursion,
Proteinqure,
Benchsci,
Insilico Medicine,
Atomwise,
Deep Genomics,
Valence Labs.
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s support email address is inquiries@cyclicarx.com
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s categories are Biotechnology Research
Cyclica (Acquired By Recursion, Nasdaq: Rxrx)'s founding year is 2013
